GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bavarian Nordic A/S (FRA:BV3) » Definitions » Total Operating Expense

Bavarian Nordic A/S (FRA:BV3) Total Operating Expense : €416.1 Mil (TTM As of Dec. 2023)


View and export this data going back to . Start your Free Trial

What is Bavarian Nordic A/S Total Operating Expense?

Bavarian Nordic A/S's Total Operating Expense for the three months ended in Dec. 2023 was €94.2 Mil. Bavarian Nordic A/S's Total Operating Expense for the trailing twelve months (TTM) ended in Dec. 2023 was €416.1 Mil.

Bavarian Nordic A/S Total Operating Expense Historical Data

The historical data trend for Bavarian Nordic A/S's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bavarian Nordic A/S Total Operating Expense Chart

Bavarian Nordic A/S Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 85.17 37.33 118.86 238.19 415.98

Bavarian Nordic A/S Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Total Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 99.09 60.98 101.64 159.31 94.16

Bavarian Nordic A/S Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €416.1 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bavarian Nordic A/S Total Operating Expense Related Terms

Thank you for viewing the detailed overview of Bavarian Nordic A/S's Total Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Bavarian Nordic A/S (FRA:BV3) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bavarian Nordic A/S (FRA:BV3) » Definitions » Total Operating Expense
Comparable Companies
OCSE:GUBRA OCSE:PEG OCSE:ALK B OCSE:ZEAL OCSE:NOVO B VRTX REGN ASX:CSL XKRX:207940 MRNA XKRX:068270 XBRU:ARGX XBRU:UCB BNTX OCSE:GMAB ALNY BGNE BMRN SZSE:300122 RPRX
Traded in Other Exchanges
BVNRY:USA BVNKF:USA BAVAc:UK 0DPB:UK BAVA:Denmark
Address
Philip Heymans Alle 3, Hellerup, DNK, DK-2900
Website
https://www.bavarian-nordic.com
Bavarian Nordic A/S is a biotechnology company focused on the development, manufacturing, and commercialization of cancer immunotherapies and vaccines for infectious diseases. The company has a specific focus on diseases for which the unmet medical need is high. Bavarian generates revenue through government research and development and supply contracts, and from its commercial partnerships. The vast majority of the company's revenue is generated in the United States, Germany, and other geographic markets.

Bavarian Nordic A/S (FRA:BV3) Headlines

No Headlines